Amgen, Inc. (NASDAQ:AMGN)
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
marsuculix
(< 20)
Submitted: 5/23/2013 7:27:02 AM :
Start Price:
$103.04
AMGN Score:
+2.50
upcoming ASCO 2013 could dive this stock uphill !
Recs
theo20
(< 20)
Submitted: 3/28/2013 4:35:07 PM :
Start Price:
$102.17
AMGN Score:
-1.70
inertia or momentum
Recs
bclan13
(99.31)
Submitted: 2/5/2013 2:14:55 AM :
Start Price:
$85.23
AMGN Score:
-14.53
I don't see anything replacing the big supportive care indications, which will probably get cut in half in coming years by a combination of biosimilars and increasing price sensitivity by numerous governments. This said,, it's a hard call for me be ause Amgen all of a sudden appears to have a phenomenal government affairs dept, securing some positive legislation in the most recent fiscal cliff deal
Recs
JorgeAura
(21.21)
Submitted: 2/2/2013 4:54:07 PM :
Start Price:
$84.60
AMGN Score:
-15.44
Nasdaq in maximums.
Recs
Recs
jrai
(< 20)
Submitted: 7/23/2012 12:15:29 PM :
Start Price:
$75.43
AMGN Score:
+17.65
I have an option which expires middle of 2013.
The exercise rate is $65.
At what price does the board think is the best price over this period to exercise the option?
Thanks for your help
Recs
jamescraymond
(< 20)
Submitted: 5/8/2012 11:16:47 AM :
Start Price:
$68.01
AMGN Score:
+33.75
Amgen will continue to innovate and perform like a midsize company. There will always be a demand for new bio pharm products.
Recs
eblasy
(< 20)
Submitted: 12/21/2011 11:21:38 AM :
Start Price:
$60.54
AMGN Score:
+40.90
This company will outperform the S&P because is was practicaly the original Biotech company. If there is going to be an advance in Biotechnology, this is the company to look for it in. Even though you shouldn't go for the big companies, this is the time to pick because there is going to be an advance in biotech very soon.
Recs
portefeuille
(99.78)
Submitted: 12/15/2011 9:24:07 PM :
Start Price:
$46.34
AMGN Score:
+40.52
There are currently 650 AMGN shares in my "fund" with break-even of around 59.13 USD.
http://caps.fool.com/Blogs/fund-trades/678775.
Recs
Recs
KittyLitterClump
(75.19)
Submitted: 4/18/2011 12:44:40 PM :
Start Price:
$52.95
AMGN Score:
+73.03
Could a dividend be in the future?
I smell one coming......
Recs
UninformedPicks
(72.78)
Submitted: 3/16/2011 12:32:45 PM :
Start Price:
$50.96
AMGN Score:
+77.91
Looks fundamentally undervalued
Recs
Whizkid81
(54.02)
Submitted: 3/2/2011 11:39:27 AM :
Start Price:
$49.74
AMGN Score:
+87.15
Great value...Biotechnology stock trading well below it s 52 week high
Recs
dataguru61
(66.17)
Submitted: 2/26/2011 7:20:48 PM :
Start Price:
$50.36
AMGN Score:
+86.12
AMGN's Product line continues to expand.. no reason to bet against this winner!
Recs
syljtffreedom
(78.02)
Submitted: 2/23/2011 2:09:39 PM :
Start Price:
$49.51
AMGN Score:
+87.92
good cash balances
Recs
UpPeriscope1
(37.73)
Submitted: 2/22/2011 8:32:26 PM :
Start Price:
$49.89
AMGN Score:
-87.10
Underperform
Recs
rofgile
(98.99)
Submitted: 2/15/2011 5:41:56 PM :
Start Price:
$51.28
AMGN Score:
+82.93
Biotech watchlist
Recs
RevelationMan
(< 20)
Submitted: 1/13/2011 3:20:23 AM :
Start Price:
$54.53
AMGN Score:
+65.97
Go long and strong and grab anything under $60.
Recs
getoutngo
(< 20)
Submitted: 12/7/2010 2:02:08 PM :
Start Price:
$51.16
AMGN Score:
-73.53
If 2011's revenue and earnings are stagnant, where exactly is the growth coming from to propel the shares in the next 12 months?
Recs
EpiphanyStock
(30.24)
Submitted: 12/6/2010 4:26:12 PM :
Start Price:
$51.55
AMGN Score:
+72.35
a biotech stock trading at big pharma prices.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 328 : 1 2 3 4 5 6 7 8 9 10 Next »